CN Patent

CN103860459A — 一种坎格雷洛注射剂及其制备方法

Assigned to Tianjin Hankang Pharmaceutical Biotechnology Co Ltd · Expires 2014-06-18 · 12y expired

What this patent protects

本发明涉及一种坎格雷洛注射剂及其制备方法，特别是一种用于治疗急性血栓性脑梗塞及脑梗塞所伴随的运动性障碍的坎格雷洛注射剂，优选的是注射液和冻干粉针。本发明的坎格雷洛注射剂主要是由活性成分坎格雷洛和辅料氢氧化钠、枸橼酸组成。发明的注射液中溶媒为注射用水；冻干粉针中赋形剂为甘露醇和/或山梨醇，可任选一种或两种任意药用比例组合，即可不加任何一种赋形剂。

USPTO Abstract

本发明涉及一种坎格雷洛注射剂及其制备方法，特别是一种用于治疗急性血栓性脑梗塞及脑梗塞所伴随的运动性障碍的坎格雷洛注射剂，优选的是注射液和冻干粉针。本发明的坎格雷洛注射剂主要是由活性成分坎格雷洛和辅料氢氧化钠、枸橼酸组成。发明的注射液中溶媒为注射用水；冻干粉针中赋形剂为甘露醇和/或山梨醇，可任选一种或两种任意药用比例组合，即可不加任何一种赋形剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN103860459A
Jurisdiction
CN
Classification
—
Expires
2014-06-18
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Hankang Pharmaceutical Biotechnology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.